## Abstract Human papillomavirus type 16 (HPV‐16) classes (E, AA, As, Af1, Af2) and their variants have different geographic distribution and different degrees of association with cervical lesions. This study was designed to examine HPV‐16 variants among Italian women and their prevalence in case p
Thes physical state of human papillomavirus 16 DNAxs in cervical carcinoma and cervical intraepithelial neoplasia
✍ Scribed by M. Fukushima; Y. Yamakawa; S. Shimano; M. Hashimoto; Y. Sawada; K. Fujinaga
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 671 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Infection with high‐risk human papillomavirus (HPV) causes cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (ICC). The distribution of HPV types in cervical diseases has been previously described in small studies for Canadian women. The prevalence of 36 HPV genotype
## Abstract Macao is a densely populated city situated in East Asia where a relatively high prevalence of human papillomavirus (HPV) types 52 and 58 has been reported in women with invasive cervical cancer. To provide data for a population‐specific estimation on the impact of HPV vaccines, paraffin
## Abstract We aimed to assess the distribution of human papillomavirus (HPV) genotypes in high‐grade cervical lesions in Taiwan. The study included 1,086 paraffin‐embedded, formaldehyde‐fixed cervical intraepithelial neoplasia (CIN) 2/3 specimens. HPV genotyping was performed using polymerase chai
## Abstract We assessed prospectively whether residual cervical intraepithelial neoplasia (CIN) after treatment for high‐grade CIN can be predicted by genotype‐specific high‐risk HPV (HR‐HPV) detection in follow‐up cervical scrapes. A broad spectrum, highly sensitive SPF~10~‐LiPA‐PCR HPV detection
## Abstract Infection with the human papillomavirus (HPV) is responsible for 99.7% of cervical cancers, the second most prevalent neoplasia in women worldwide and the fifth leading cause of death by cancer in this population. In Chile, the incidence rate is 14.4 cases per 100,000 women per year and